Bayer inaugurates new phytomedicines lab facility
The lab will facilitate the development of herbal and natural-based solutions
The lab will facilitate the development of herbal and natural-based solutions
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
The inspection was carried out between May 26, 2025 and May 31, 2025
The cGMP-4 facility will further strengthen the company's ability to serve global partners
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Lupin will address the observations and respond to the U.S. FDA within the stipulated timeframe
Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner
The U.S. FDA issued a Form 483 with five observations
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
Subscribe To Our Newsletter & Stay Updated